Financial Daily from THE HINDU group of publications
Saturday, November 29, 2003
Markets (Nov. 28)
BL 2501791.23 (+22.34)
BSE Sensex5044.82 (+55.78)
S&P CNX Nifty1615.25 (+16.90)
US Dollar (Buy/Sell)45.83/45.96
Gold Std (10 gm)6010 (+40)

News
Features
Stocks
Port Info
Archives


Subscription

Group Sites

CORPORATE

RESEARCH & DEVELOPMENT


Lombardini plans R&D unit in India
ENGINE manufacturing company, Lombardini S.R.I of Italy, which has a 100 per cent subsidiary in India, is planning to invest $10-12 million in India over the next 3-4 years towards setting up a research and development centre. The company has ... More

ANNOUNCEMENTS


GEAC allegations over Shankinase — Shantha Bio says it followed procedures
SHANTHA Biotechnics Pvt Ltd on Friday asserted that it has followed full regulatory procedures as specified by the Department of Biotechnology (DBT) in getting its recombinant clot-buster drug - Shankinase - approved for clinical trials and ... More

Glenmark introduces cardiac drug in Canada
GLENMARK Pharmaceuticals, an R&D-based pharma company with presence in both the formulations and bulk drugs sector, has commenced supply of Amiodarone, a new general bulk drug in the cardiac segment, to the Canadian market. The company expects ... More

Piaggio to use Baramati plant for exports
ITALIAN auto maker Piaggio said today that it plans to manufacture up to 50 per cent of its volume requirements of the new four-wheeler, slated to be launched for the European market in 2004, in its Indian factory in Baramati in Maharashtra. ... More

Ventura Textiles plans to delist from 3 SEs
VENTURA Textiles Corporation Ltd has informed the Bombay Stock Exchange that its board, in its meeting held on Thursday, had recommended, subject to the approval of members, the voluntary delisting of the company's shares from the Ahmedabad, ... More

  • Aventis scheme
  • Zenith informs BSE on delist of shares

    OPEN OFFERS


    Ashika offer for shares in Gandhidham Spinning
    ASHIKA Capital Ltd, manager to the offer on behalf of Mr Parasmal Munilal Jain, Mrs Kamaladevi Parasmal Jain, Mr Pradeep Parasmal Jain, Mr Sandeep Parasmal Jain, Sukhraj Amarchand Singhvi, Mr Babulal Amarchand Singhvi, Mr Ashokkumar Amarchand ... More

    COMPANY LAW


    Qualified Co. Secys in small towns — DCA urged to review decision
    THE Institute of Company Secretaries of India (ICSI) has urged the Department of Company Affairs (DCA) to reconsider its recent amendments that exclude companies located in smaller places from the services of a qualified company secretary (CS) ... More

    RESTRUCTURING


    Merven board meet to clear reverse merger
    MERVEN Drug Products Ltd (MDPL), currently under the purview of the Board for Industrial and Financial Reconstruction (BIFR), has on Friday informed the stock exchanges that the meeting of its Board of Directors would be held on December 8 to ... More

    MERGERS & ACQUISITIONS


    Tata Motors not keen on Ssangyong stake
    On two previous occasions, Ssangyong products were reported as India-bound, both through a likely tie-up with domestic utility vehicles major Mahindra & Mahindra Ltd (M&M). More

    Suven board to consider merger of subsidiary
    SUVEN Pharmaceuticals Ltd has informed the stock exchanges that a meeting of its board of directors would be held on December 4 to consider the merger of its subsidiary — Suven Synthesis Ltd — into the company. The board would also ... More

    NEW PROJECTS


    Polyplex board okays PET film line
    POLYPLEX Corporation Ltd has informed the BSE that the company's board of directors, in a meeting held on November 27, approved the setting up of a Polyester film line with a capacity of 24,000 m.t per annum at its existing plant site at ... More

    ALLIANCES & JOINT VENTURES


    Nicholas Piramal in pact with global majors
    NICHOLAS Piramal India Ltd has announced marketing tie-ups with Biogen Idec, France, and Chiese Farmaceutici, Italy, as part of its plans to increase the existing product line. "The tie-up will help us to bring new therapies to the Indian ... More

    Matrix to set up 2 joint ventures with German co
    MATRIX Laboratories Ltd (MLL) has decided to set up two joint ventures with German collaboration, one in India and the other in Ireland. The Hyderabad-based pharmaceutical company informed the stock exchanges that its board has approved the ... More

    Abhishek Ind ties up with L&T for towel project construction
    ABHISHEK Industries Ltd has informed the Bombay Stock Exchange that it has entered into a contract with Larsen & Toubro Ltd to carry out the construction of its terry towel expansion project, the civil works of which has already started. The ... More

    INTERVIEW


    `FACT banks on timely fiscal relief for revival' — Plans EGM on Dec 30 to discuss net worth erosion
    FERTILISERS and Chemicals Travancore Ltd (FACT) in Kerala could turn into a profit-making company if timely fiscal reliefs are provided and disinvestment is not the only solution to revive it, according to its Chairman- cum-Managing Director ... More

    `Pharma packaging heightens brand awareness'
    IN tandem with the growth of the Indian pharmaceutical industry, the pharma packaging industry is also growing at a fast clip. Entry of new players and introduction of new technologies have changed the face of the industry. And with new drugs and ... More

    OUTLOOK


    Hyundai India to launch another Accent variant — Plans major export push for engines next year
    HYUNDAI Motor India plans to launch another variant of its mid-size Accent - a CRDi (Common Rail Direct Injection) fitted Accent Viva, the five-door car. The launch is expected in the next couple of months and with this, the number of Accent ... More

    Brother group hopes to exploit garment export boom
    THE Singapore-based Brother International, which sells industrial sewing machines in India, expects to cash in on the growth of garment exports. In 2005 the quotas for garments will be gone, and Brother expects India to do well in garment ... More

    Inlingua bullish on India; targets Rs 300-cr turnover in 5 years
    JURG Heiniger, President of the $300-million Inlingua International, a Switzerland-based language training company, is bullish on India with the opening of their second centre in Delhi. The company is currently in talks with "several right ... More

    PEOPLE


    Aventis Pharma gets new MD
    THE board of directors of Aventis Pharma Ltd has informed the BSE of the appointment of Mr Alexandre de Carvalho as the Managing Director of the company. The decision was taken at the board meeting held on Thursday, the company said in a ... More
    Scoreboard
    SE Diary
    Comments & Letters to the Editor to: bleditor@thehindu.co.in
    Subscribe to: Business Line
  • The Hindu eBooks

    Mid-Term Monetary and Credit Policy for the year 2003-2004

    Pick a Winner Stock Market Contest

    Top Stories
    Rising wheat prices may spell end of party for biscuit cos


    Chinese eyeing a slice of India's fast-food pie

    EU must engage with new India: Sinha

    Soyameal exports face wagon hurdles

    Pharma cos urged to cut prices for Govt AIDS programme — Announcement likely on Sunday

    Sensex crosses 5000 as bull run continues

    In Focus
    Housing finance scenario
    Insurance Round-up — 2003
    Rising intolerance
    (The Hindu)
    Vaishnavaite Temples in Tamil Nadu
    (The Hindu)
    Saivite Temples in Tamil Nadu
    (The Hindu)
    Organic farming
    The Cable tangle
    Telecom Competition
    Oil PSUs: Disinvestment dilemma
    In Depth
    Insurance Corner
    Swati CA
    Simple Economics
    Slowburn
    Tax Talk
    NRIs & Investment Avenues
    Iraq Diary

    Looking back
    Nov. 16-Nov. 22
    Redrafted cos Bill to be more liberal

    Govt sets up body to handle corporate governance issues


    The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
    Group Sites: The Hindu | Business Line | The Sportstar | Frontline | The Hindu eBooks | Home |

    Copyright 2003, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line